From Prototype to Profit: Commercialization Insights

Tracking companies turning innovation into revenue – and the milestones that matter.

NT
Editor
Nancy Torres

About This Column

Nancy Torres's column, 'From Prototype to Profit: Commercialization Insights,' dives deep into the critical journey companies take from development to market success. Unlike typical financial news, this column focuses on the how – the key milestones like regulatory approvals, strategic partnerships, product launches, and funding rounds that directly enable revenue generation. Nancy provides insightful analysis of companies navigating this complex path, identifying promising ventures and flagging potential pitfalls for investors, industry analysts, and business leaders. She examines a diverse range of industries – from biotech and robotics to retail and REITs – providing a unique perspective on what it really takes to translate innovation into lasting commercial viability. Readers will gain actionable insights into emerging trends and a deeper understanding of the forces shaping the future of business.

Displaying articles 21–40 of 272 in total

Kelsey Plum's AI Twin: A New Era for Athlete Empowerment and Digital Identity

Read full article
Kelsey Plum's AI Twin: A New Era for Athlete Empowerment and Digital Identity

Texas Hispanic Voters: We're Decisive, Ignored, and Want Economic Action

Read full article
Texas Hispanic Voters: We're Decisive, Ignored, and Want Economic Action

Lithium Africa Secures C$8.5M to Advance South African Lithium Project

Read full article
BriefGlance

Simeone Museum's Sebring Tribute Revs Up for America's 250th

Read full article
Simeone Museum's Sebring Tribute Revs Up for America's 250th

Seal Shield Acquires Vioguard, Fortifying Arsenal Against Superbugs

Read full article
Seal Shield Acquires Vioguard, Fortifying Arsenal Against Superbugs

WEBTOON Taps IPO Architect as President to Reignite Growth

Read full article
WEBTOON Taps IPO Architect as President to Reignite Growth

Altimmune's Liver Drug Gains FDA Breakthrough Status, Eyes MASH Market

Read full article
Altimmune's Liver Drug Gains FDA Breakthrough Status, Eyes MASH Market

The Connected Crib: Can Tech Ease the Burden for Modern Parents?

Read full article
BriefGlance

NFP Acquires Trinity Risk, Launches Captive Practice for Mid-Market

Read full article
NFP Acquires Trinity Risk, Launches Captive Practice for Mid-Market

Luxury's New Era: Redefining Value Beyond the Price Tag in 2026

Read full article
BriefGlance

Codis Unlocks UK Pharma Future with Landmark Manufacturing Investment

Read full article
Codis Unlocks UK Pharma Future with Landmark Manufacturing Investment

Eric Favre: A French Nutrition Giant Built on Quality and Dual-Market Rule

Read full article
Eric Favre: A French Nutrition Giant Built on Quality and Dual-Market Rule

A Breath of Hope: VentFree Trial Nears Finish Line for ICU Patients

Read full article
A Breath of Hope: VentFree Trial Nears Finish Line for ICU Patients

Quantexa and Moody’s Forge AI Alliance to Redefine Enterprise Risk

Read full article
Quantexa and Moody’s Forge AI Alliance to Redefine Enterprise Risk

Fasting Without the Hunger: Mimio Health's Clinically-Backed Pill

Read full article
Fasting Without the Hunger: Mimio Health's Clinically-Backed Pill

Lexus UPTOWN Honors Hollywood's Enduring Black Male Icons

Read full article
Lexus UPTOWN Honors Hollywood's Enduring Black Male Icons

Ohio Water War: Locals Demand Halt to Waste Injection Wells

Read full article
BriefGlance

A Lifetime of Hope: Sara O'Meara Honored for Child Advocacy Legacy

Read full article
A Lifetime of Hope: Sara O'Meara Honored for Child Advocacy Legacy

AI Tool Approved to Boost Australia's Lung Cancer Survival Rates

Read full article
AI Tool Approved to Boost Australia's Lung Cancer Survival Rates

From At-Risk to CEO: A Fitness Mogul's Plan to Empower Youth

Read full article
From At-Risk to CEO: A Fitness Mogul's Plan to Empower Youth
UCID: 15